| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 17.756 | 4.032 | 4.665 | 4.646 | 5.103 | 5.148 | 5.598 | 5.814 | 4.555 | 0 |
| Total Income - EUR | 17.756 | 4.032 | 4.665 | 4.646 | 7.398 | 5.722 | 5.599 | 6.783 | 11.607 | 0 |
| Total Expenses - EUR | 22.256 | 8.475 | 8.554 | 8.889 | 8.551 | 8.216 | 8.748 | 9.717 | 10.353 | 17 |
| Gross Profit/Loss - EUR | -4.500 | -4.443 | -3.889 | -4.244 | -1.154 | -2.494 | -3.149 | -2.935 | 1.254 | -17 |
| Net Profit/Loss - EUR | -5.037 | -4.539 | -3.965 | -4.290 | -1.228 | -2.529 | -3.163 | -2.935 | 1.058 | -17 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Sanomed Impex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.510 | 906 | 1.565 | 1.363 | 1.168 | 2.438 | 1.947 | 1.563 | 0 | 0 |
| Current Assets | 457 | 488 | 237 | 259 | 320 | 493 | 324 | 450 | 3.285 | 2.445 |
| Inventories | 64 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 286 | 437 | 199 | 226 | 245 | 241 | 235 | 236 | 0 | 0 |
| Cash | 108 | 51 | 38 | 33 | 75 | 253 | 89 | 214 | 3.285 | 2.445 |
| Shareholders Funds | -5.260 | -9.746 | -13.545 | -17.587 | -18.474 | -20.652 | -23.358 | -26.365 | -25.228 | -25.104 |
| Social Capital | 48 | 47 | 47 | 46 | 45 | 44 | 43 | 43 | 43 | 43 |
| Debts | 7.228 | 11.139 | 15.347 | 19.210 | 19.962 | 23.584 | 25.629 | 28.378 | 28.513 | 27.549 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4532 - 4532" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Sanomed Impex Srl